Scientists say their Rutava technology able to target cancerous cells only, raising hopes for cure for all cancers
Vous n'êtes pas connecté
In a new study, clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) have demonstrated the use of exosomes to successfully target squamous cell cancer tumours that are usually resistant to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). Their research is the first where exosomes have been applied to target TKI-resistant cancers in [...]
Scientists say their Rutava technology able to target cancerous cells only, raising hopes for cure for all cancers
Scientists say their Rutava technology able to target cancerous cells only, raising hopes for cure for all cancers
In a study using human breast cancer cells, scientists say they have potentially identified immune system white blood cells that appear to be the...
Lowering the dose of anti-cancer drugs well below the standard treatment threshold has shown promise in improving tumours’ response to...
Lowering the dose of anti-cancer drugs well below the standard treatment threshold has shown promise in improving tumours’ response to...
Prostate cancer is the second most common cancer among men worldwide, following lung cancer. In the United States alone, nearly 300,000 new cases are...
Prostate cancer is the second most common cancer among men worldwide, following lung cancer. In the United States alone, nearly 300,000 new cases are...
Researchers have made a significant breakthrough in understanding how oral cancer cells evade the body's immune system, leading to potential new...
Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins...
Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins...